Stock Events

Stock Events

Lindbergh S.p.a. 

$9.94
139
+$0.00+0% Tuesday 12:05

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

11NovExpected
Q1 2025
Q3 2025
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

Financials

12.91%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
7.66BRevenue
988.97MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow LDBMF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap149.38B
Pfizer is a global pharmaceutical company that competes with Lundbeck in the development and marketing of drugs for psychiatric and neurological disorders.
Johnson & Johnson
JNJ
Mkt Cap579.83B
Johnson & Johnson, through its Janssen Pharmaceuticals division, competes in the same therapeutic areas as Lundbeck, including mental health.
Novartis
NVS
Mkt Cap292.07B
Novartis offers products in neurology and psychiatry, directly competing with Lundbeck's portfolio.
Lilly(Eli) &
LLY
Mkt Cap1.01T
Eli Lilly has a strong presence in the psychiatric medication market, making it a direct competitor to Lundbeck.
Merck
MRK
Mkt Cap294.03B
Merck & Co. competes with Lundbeck in the area of brain health, including treatments for neurological conditions.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap40.32B
Teva Pharmaceutical Industries has a broad portfolio that includes CNS (central nervous system) drugs, competing with Lundbeck.
Abbvie
ABBV
Mkt Cap402.35B
AbbVie, with its neuroscience division, offers products that compete in the same space as Lundbeck's treatments.
Bristol-Myers Squibb
BMY
Mkt Cap116.66B
Bristol Myers Squibb has a range of psychiatric and neurological drugs, positioning it as a competitor to Lundbeck.
Astrazeneca
AZN
Mkt Cap277.22B
AstraZeneca operates in various therapeutic areas, including those that overlap with Lundbeck's CNS focus.
GSK
GSK
Mkt Cap106.31B
GlaxoSmithKline has a diversified portfolio that includes medications for mental health, competing with Lundbeck.

About

Lindbergh S.p.A., together with its subsidiaries, provides logistics services in Italy and France. The company offers logistics services for networks of field maintenance technicians, including night distribution of spare parts, special waste and returns management, spare parts stock management, tools management and testing, and onsite services, as well as tools management and testing, PPE, and consumables services. It is also involved in circular economy projects, as well as servicing and installing activities in the heating, ventilation, and air conditioning sector. The company was founded in 2006 and is based in Cremona, Italy.
Show more...
CEO
ISIN
IT0005469272

Listings

F
DE
D8M.F
Grey Market
US
LDBMF
STU
DE
LDBA.STU
MU
DE
LDBA.MU

0 Comments

Share your thoughts

FAQ

What is Lindbergh S.p.a. stock price today?▼
The current price of LDBMF is $9.94 USD — it has increased by +0% in the past 24 hours. Watch Lindbergh S.p.a. stock price performance more closely on the chart.
What is Lindbergh S.p.a. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Lindbergh S.p.a. stocks are traded under the ticker LDBMF.
What is Lindbergh S.p.a. revenue for the last year?▼
Lindbergh S.p.a. revenue for the last year amounts to 7.66B USD.
What is Lindbergh S.p.a. net income for the last year?▼
LDBMF net income for the last year is 988.97M USD.
In which sector is Lindbergh S.p.a. located?▼
Lindbergh S.p.a. operates in the Other sector.
When did Lindbergh S.p.a. complete a stock split?▼
Lindbergh S.p.a. has not had any recent stock splits.